Watch ISAB CEO go behind the headlines in high-value Q1 interview

Inhalation Sciences CEO Manoush Masarrat discusses the company’s recent Q1 Report, and takes investors’ questions, in the first of a new regular series.

Watch the interview here.

Together with analyst Jonathan Furelid ISAB’s CEO analyzes the Company’s recent Q1 results, taking investor’s questions and adding significant business intelligence and insights. The interview is the first in a series of Quarterly videos that will run through 2024.

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalation Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.

Tags: